Active Stocks
Thu Nov 21 2024 15:58:46
  1. Tata Steel share price
  2. 140.25 0.57%
  1. Tata Motors share price
  2. 773.70 -1.24%
  1. State Bank Of India share price
  2. 780.85 -2.64%
  1. NTPC share price
  2. 356.10 -2.73%
  1. Power Grid Corporation Of India share price
  2. 325.80 3.41%
Business News/Market/Market Stats/    Suven Pharmaceuticals

SUVEN PHARMACEUTICALS SUMMARY

Suven Pharmaceuticals is trading 0.27% lower at Rs 1276.00 as compared to its last closing price. Suven Pharmaceuticals has been trading in the price range of 1281.5 & 1260.05. Suven Pharmaceuticals has given 77.03% in this year & 2.31% in the last 5 days.

 

Suven Pharmaceuticals has TTM P/E ratio 122.75 as compared to the sector P/E of 31.15. There are 1 analysts who have initiated coverage on Suven Pharmaceuticals. There are 1 analysts who have given it a strong buy rating & 0 analysts have given it a buy rating. 0 analysts have given the stock a sell rating.

 

The company posted a net profit of 82.21 Crores in its last quarter.

 

Listed peers of Suven Pharmaceuticals include Ajanta Pharmaceuticals (-0.05%), Syngene International (-0.31%), Suven Pharmaceuticals (-0.27%) etc.

 

Suven Pharmaceuticals has a 50.1% promoter holding & 49.9% public holding.

FAQs about Suven Pharmaceuticals

Suven Pharmaceuticals is trading at 1276.00 as on 21 Nov, 2024 3:28:56 PM. This is -0.27% lower as compared to its previous closing price of 1279.5
The market capitalization of Suven Pharmaceuticals is 32572.86 Cr as on 21 Nov, 2024 3:28:56 PM.
The average broker rating on Suven Pharmaceuticals is Strong Buy. The breakup of analyst rating is given below -
  • 0 analysts have given a strong sell rating
  • 0 analysts have given a sell rating
  • 0 analysts have given a hold rating
  • 0 analysts have given a buy rating
  • 1 analysts have given a strong buy rating
The 52 wk high for Suven Pharmaceuticals is 1358.75 whereas the 52 wk low is 578.05
Suven Pharmaceuticals can be analyzed on the following key metrics -
  • TTM P/E: 122.75
  • Sector P/E: 31.15
  • Dividend Yield: 0%
  • D/E ratio: -
Suven Pharmaceuticals reported a net profit of 300.28 Cr in 2024.
Recommended For You